Type 2 diabetes trials in Slovakia
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleAMBITION 1: A research study investigating how well zenagamtide lowers blood sugar and body weight compared to placebo in people with type 2 diabetes treated with diet and exercise.
- Where
- Bytca, Devinska Nova Ves, Košice, Nové Zámky, Šurany, Trnava
- Age
- 18 years and over
- People
- 85 worldwide
- Run by
- Novo Nordisk A/S
See details and how to join2026-525470-18-00 · EU 2026-525470-18-00 - Phase 3Taking peopleAMBITION 3: A research study investigating how well zenagamtide at higher dose levels lowers blood sugar and body weight compared to semaglutide in people with type 2 diabetes treated with metformin, SGLT2i, or both
- Where
- Bardejov, Kosice 1, Martin, Poprad, Spisska Nova Ves, Svidnik
- Age
- 18 years and over
- People
- 595 worldwide
- Run by
- Novo Nordisk A/S
See details and how to join2026-525472-26-00 · EU 2026-525472-26-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Bratislava, Malacky, Nové Zámky, Púchov, Sabinov, Žilinský kraj
- Age
- 18 years and over
- People
- 1,035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - Phase 3Taking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Bojnice, Bratislava, Lučenec, Martin, Namestovo, Rožňava, Trebišov, Vrútky, Zilina
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Banská Bystrica, Bardejov, Bratislava, Košice, Moldava nad Bodvou, Poprad, Svidník, Trnava
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Bratislava, Košice, Lučenec, Námestovo, Prievidza, Rožňava, Trebišov
- Age
- 18 years and over
- People
- 1,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - Phase 3Taking peopleA Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
- Where
- Bratislava, Košice, Lučenec, Namestovo, Prievidza, Rožňava, Trebišov
- Age
- 18 years and over
- People
- 420 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524616-11-00 · EU 2025-524616-11-00 - Phase 2Taking peopleA Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Lučenec, Petrzalka, Sabinov, Trebišov
- Age
- 18 years to 75 years
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00 - Phase 3Taking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Bojnice, Bytca, Devinska Nova Ves, Košice, Kosice 1, Martin, Petrzalka, Spišská Nová Ves
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - Phase 2Taking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Bardejov, Bratislava, Malacky, Stare Mesto
- Age
- 18 years to 75 years
- People
- 270 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07415954 · EU 2025-523260-20-00 - Phase 3Taking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Where
- Bratislava, Košice, Martin, Námestovo, Poprad, Rožňava
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00 - No phaseTaking peopleGastric Pathophysiology in Diabetes
- Where
- Trnava
- Age
- 18 years to 70 years
- People
- 120 worldwide
- Run by
- Institute for Clinical and Experimental Medicine
See details and how to joinNCT06068114